Functional analysis of a recombinant PIII-SVMP, GST-acocostatin; an apoptotic inducer of HUVEC and HeLa, but not SK-Mel-28 cells

Toxicon

Volumn 57, Issue 5, 2011, Pages 646-656

  Teklemariam, Takele ^a   Seoane, Agustin I ^a   Ramos, Carla J ^a   Sanchez, Elda E ^b   Lucena, Sara E ^b   Perez, John C ^b   Mandal, Stephanie A ^a   Soto, Julio G ^a  

^a SAN JOSE STATE UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY KINGSVILLE   (United States)

Author keywords

Apoptosis; Cell adhesion assays; PIII SVMP; Recombinant disintegrin like

Indexed keywords

ANNEXIN; COMPLEMENTARY DNA; DISINTEGRIN; GLUTATHIONE TRANSFERASE ACOCOSTATIN FUSION PROTEIN; HYBRID PROTEIN; INTEGRIN; INTEGRIN RECEPTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL MIGRATION; CHROMATIN; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG PURIFICATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FRAGMENTATION REACTION; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

AGKISTRODON; ANIMALS; APOPTOSIS; CELL MOVEMENT; CHROMATIN; DISINTEGRINS; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMANS; INTEGRINS; MICROSCOPY, FLUORESCENCE; PEPTIDES; PLATELET AGGREGATION; RECOMBINANT PROTEINS; SNAKE VENOMS; UMBILICAL VEINS;

AGKISTRODON CONTORTRIX CONTORTRIX;

EID: 79953272002     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2011.01.007     Document Type: Article

References (54)

1. Aidoudi A., Bujakowski K., Kieffer N., Bikfalvi A. The CXC-chemokine CXCL4 interacts with integrins implicated with angiogenesis. PLOS One 2008, 3:1-14.
2. Araki S., Masuda S., Maeda H., Ying M.J., Hayashi H. Involvement of specific integrins in apoptosis induced by vascular apoptosis-inducing protein 1. Toxicon 2002, 40:535-542.
3. Barczyk M., Carracedo S., Gullberg D. Integrins. Cell Tissue Res. 2010, 339:269-280.
4. Beauvais D.M., Ell B.J., McWhorter A.R., Rapraeger A.C. Syndecan-1 regulates avb3 and avb5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J. Exp. Med. 2009, 206:691-705.
5. Brooks P.C., Montgomery A.M., Rosenfeld M., Reisfeld R.A., Hu T., Klier G., Cheresh D.A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79:1157-1164.
6. Brooks P.C., Stromblad S., Klemke R., Visscher D., Sarkar F.H., Cheresh D.A. Anti-integrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 1995, 96:1815-1822.
7. Calvete J.J., Marcinkiewicz C., Monleon D., Esteve V., Celda B., Juarez P., Sanz L. Snake venom disintegrins: evolution of structure and function. Toxicon 2005, 45:1063-1074.
8. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
9. Chang H.H., Hu S.T., Huang T.F., Chen S.H., Lee Y.H., Lo S.J. Rhodostomin, an RGD-containing peptide expressed from a synthetic gene in Escherichia coli, facilitates the attachment of human hepatoma cells. Biochem. Biophys. Res. Commun. 1993, 190:242-249.
10. Dennis M.S., Henzel W.J., Pitti R.M., Lipari M.T., Napier M.A., Deisher T.A., Bunting S., Lazarus R.A. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc. Natl. Acad. Sci. U S A 1990, 87:2471-2475.
11. Eliceiri B.P., Cheresh D.A. The role of alphav integrins during angiogenesis:insights into potential mechanisms of action and clinical development. J. Clin. Invest. 1999, 103:1227-1230.
12. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 1992, 267:10931-10934.
13. Fox J.W., Serrano S.M. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 2005, 45:969-985.
14. Fox J.W., Serrano S.M. Insights and speculations into snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J. 2008, 275:3016-3030.
15. Gould R.J., Polokoff M.A., Friedman P.A., Huang T.F., Holt J.C., Cook J.J., Niewiarowski S. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exp. Biol. Med. 1990, 195:168-171.
16. Guohong L., Jin R., Norris R.A., Zhang L., Yu S., Wu F., Markwald R.R., Nanda A., Conway S.J., Smyth S.B., Granger D.N. Periostin mediates smooth muscle migration through the integrins avb3 and avb5 and focal adhesion kinase (FAK) pathway. Atheriosclerosis 2010, 208:358-365.
17. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2002, 2:91-100.
18. Hsu A.R., Veeravagu A., Cai W., Hou L.C., Tse V., Chen X. Integrin alpha vbeta 3 antagonists for anti-angiogenic cancer treatment. Recent Pat. Anticancer Drug Discov. 2007, 2:143-158.
19. Huveneers S., Truong H., Danen H.J. Integrins: signaling, disease, and therapy. Int. J. Radiat. Biol. 2007, 83:743-751.
20. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
21. Igarashi T., Araki S., Mori H., Takeda S. Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins. FEBS Lett. 2007, 581:2416-2422.
22. Jia L.G., Wang X.M., Shannon J.D., Bjarnason J.B., Fox J.W. Inhibition of platelet aggregation by the recombinant cysteine-rich domain of the hemorrhagic snake venom methalloproteinase, atrolysin-A. Arch. Biochem. Biophys. 2000, 373:281-286.
23. Kamigutti A.S., Gallagher P., Marcinkiewicz C., Theaskston R.D., Zuzel M., Fox J.W. Identification of sites in the cysteine-rich domain of the class PIII snake venom methalloproteinases responsible for inhibition of platelet function. FEBS Lett. 2003, 549:129-134.
24. Litvin J., Zhu S., Norris R., Markwald R. Periostin family of proteins:therapeutic targets for heart disease. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 2005, 287A:1205-1212.
25. Mahimkar R.M., Visaya O., Pollock A.S., Lovett D.H. The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins. Biochem. J. 2005, 385:461-468.
26. Marcinkiewicz C., Weinreb P.H., Calvete J.J., Kisiel D.G., Mousa S.A., Tuszynski G.P., Lobb R.R. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo. Cancer Res. 2003, 63:2020-2023.
27. Maruyama J., Hayashi H., Miao J., Sawada H., Araki S. Severe cell fragmentation in the endothelial cell apoptosis induced by snake apoptosis toxin VAP1 is an apoptotic characteristic controlled by caspases. Toxicon 2005, 46:1-6.
28. Masuda S., Hayashi H., Araki S. Two vascular apoptosis-inducing proteins from snake venom are members of the metalloprotease/disintegrin family. Eur. J. Biochem. 1998, 253:36-41.
29. Masuda S., Ohta T., Kaji K., Fox J.W., Hayashi H., Araki S. cDNA cloning and characterization of vascular apoptosis-inducing protein 1. Biochem. Biophys. Res. Commun. 2000, 278:197-204.
30. McLane M.A., Sanchez E.E., Wong A., Paquette-Straub C., Perez J.C. Disintegrins. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2004, 4:327-355.
31. McLane M.A., Joerger T., Mahmoud A. Disintegrins in health and disease. Front. Biosci. 2008, 13:6617-6637.
32. Menezes M.C., Paes A.D.L., Melo R.L., Silva C.A., Della Casa M., Bruni F.M., Lima C., Lopes-Ferreira M., Camargo A.C.M., Fox J.W., Serrano S.M.T. Activation of leukocyte rolling by the cysteine-rich domain and the hypervariable region HF3, a snake venom hemorrhagic metalloproteinase. FEBS Lett. 2008, 582:3915-3921.
33. Moschos S.J., Drogowski L.M., Reppert S.I., Kirkwood J.M. Integrins and cancer. Oncology 2007, 21:13-20.
34. Pinto A.F.M., Terra R.M.S., Guimaraes J.A., Fox J.W. Mapping von Willerand factor A domain binding sites on a snake venom metalloproteinase cysteine-rich domain. Arch. Biochem. Biophys. 2007, 457:41-46.
35. Radis-Baptista G. Integrins, cancer and snake toxins (mini-review). J. Venom. Anim. Toxins Incl. Trop. Dis. 2005, 11:217-241.
36. Rahman S., Aitken A., Flynn G., Formstone C., Savidge G.F. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation. Biochem. J. 1998, 335:247-257.
37. Ramos O.H., Kauskot A., Cominetti M.R., Bechyne I., Salla Pontes C.L., Chareyre F., Manent J., Vassy R., Giovannini M., Legrand C., Selistre-de-Araujo H.S., Crepin M., Bonnefoy A. A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis. Clin. Exp. Metastasis 2008, 25:53-64.
38. Sanchez E.E., Lucena S.E., Reyes S., Soto J.G., Cantu E., Lopez-Johnston J.C., Guerrero B., Salazar A.M., Rodriguez-Acosta A., Galan J.A., Tao W.A., Perez J.C. Cloning, expression, and hemostatic activities of a disintegrin, r-mojastin 1, from the mohave rattlesnake (Crotalus scutulatus scutulatus). Thromb. Res. 2010, 126:211-219.
39. Selistre-de-Araujo H.S., Cominetti M.R., Terrugi C.H.B., Mariano-Olivera A., De Freitas M.S., Crepin M., Figueiredo C.C., Morandi V. Alternagin-C, a disintegrin-like protein from the venom of Bothrops alternatus, modulates a2b1 integrin-mediated cell adhesion, migration, and proliferation. Braz. J. Med. Biol. Res. 2005, 38:1505-1511.
40. Seoane A.I., Tran V.L., Sanchez E.E., White S.A., Choi J.L., Gaytán B., Chavez N., Reyes S.R., Ramos C.J., Tran L.H., Lucena S.E., Sugarrek M., Perez J.C., Mandal S.A., Ghorab S., Rodriguez-Acosta A., Fung B.K., Soto J.G. The mojastin mutant Moj-DM induces apoptosis of the human melanoma Sk-Mel-28, but not the mutant Moj-NN nor the non-mutated recombinant Moj-WN. Toxicon 2010, 56:391-401.
41. Serrano A.M.T., Wang D., Shannon J.D., Pinto A.F.M., Polanowska-Grabowska R.K., Fox J.W. Interaction of the cysteine-rich domain of snake venom methalloproteinase with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation. FEBS J. 2007, 274:3611-3621.
42. Swenson S., Costa F., Minea R., Sherwin R.P., Ernst W., Fujii G., Yang D., Markland F.S. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol. Cancer Ther. 2004, 3:499-511.
43. Swenson S., Costa F., Ernst W., Fujii G., Markland F.S. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity. Pathophysiol. Haemost. Thromb. 2005, 34:169-176.
44. Swenson S., Ramu S., Markland F.S. Anti-angiogenesis and RGD-containing snake venom disintegrins. Curr. Pharm. Des 2007, 13:2860-2871.
45. Takeda S., Igarashi T., Mori H., Araki S. Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold. EMBO J. 2006, 25:2388-2396.
46. Trummal K., Tonismagi K., Siigur E., Aaspollu A., Lopp A., Sillat T., Saat R., Kasak L., Tammiste I., Kogerman P., Kalkkinen N., Siigur J. A novel metalloprotease from vipera lebetina venom induces human endothelial cell apoptosis. Toxicon 2005, 46:46-61.
47. Wierzbicka-Patynowski I., Niewiarowski S., Marcinkiewicz C., Calvete J.J., Marcinkiewicz M.M., McLane M.A. Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins. J. Biol. Chem. 1999, 274:37809-37814.
48. Yang R.S., Tang C.H., Chuang W.J., Huang T.H., Peng H.C., Huang T.F., Fu W.M. Inhibition of tumor formation by snake venom disintegrin. Toxicon 2005, 45:661-669.
49. You W.K., Jang Y.J., Chung K.H., Kim D.S. A novel disintegrin-like domain of a high molecular weight metalloprotease inhibits platelet aggregation. Biochem. Biophys. Res. Commun. 2003, 309:637-642.
50. You W.K., Seo H.J., Chung K.H., Kim D.S. A novel metalloprotease from Gloydius halys venom induces endothelial cell apoptosis through its protease and disintegrin-like domains. J. Biochem. 2003, 134:739-749.
51. You W.K., Jang Y.J., Chung K.H., Jeon O.H., Kim D.S. Functional roles of the two distinct domains of halysase, a snake venom metalloprotease, to inhibit human platelet aggregation. Biochem. Biophys. Res. Commun. 2006, 339:964-970.
52. Zhou Q., Nakada M.T., Brooks P.C., Swenson S.D., Ritter M.R., Argounova S., Arnold C., Markland F.S. Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5. Biochem. Biophys. Res. Commun. 2000, 267:350-355.
53. Zhou Q., Sherwin R.P., Parrish C., Richters V., Groshen S.G., Tsao-Wei D., Markland F.S. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression. Breast Cancer Res. Treat. 2000, 61:249-260.
54. Zhou Y., Hagood J.S., Lu B., Merryman W.D., Murphy-Ulrich J.E. Thy-1- Integrin avb5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-b1 activation and myofibroblast differentiation. J. Biol. Chem. 2010, 285:22382-22393.